MX2016004487A - Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados. - Google Patents

Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.

Info

Publication number
MX2016004487A
MX2016004487A MX2016004487A MX2016004487A MX2016004487A MX 2016004487 A MX2016004487 A MX 2016004487A MX 2016004487 A MX2016004487 A MX 2016004487A MX 2016004487 A MX2016004487 A MX 2016004487A MX 2016004487 A MX2016004487 A MX 2016004487A
Authority
MX
Mexico
Prior art keywords
fatty acids
polyunsaturated fatty
soft capsules
enteric soft
pharmaceutical compositions
Prior art date
Application number
MX2016004487A
Other languages
English (en)
Inventor
Zhang Peijin
A Fatmi Aqeel
Original Assignee
Banner Life Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banner Life Sciences Llc filed Critical Banner Life Sciences Llc
Publication of MX2016004487A publication Critical patent/MX2016004487A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Abstract

Se describen en la presente una composición farmacéutica que contiene ácidos grasos poliinsaturados y métodos para su fabricación. En particular, se describe en el presente composiciones farmacéuticas que consisten en cápsulas blandas entéricas que contienen ácidos grasos polinsaturados omega -3. La composición farmacéutica oral descrita en la presente es útil son útiles como suplementos nutricionales o para el tratamiento de enfermedades cardiovasculares como dislipidemia y niveles altos de triglicéridos.
MX2016004487A 2013-10-30 2014-10-29 Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados. MX2016004487A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361897794P 2013-10-30 2013-10-30
US201462017489P 2014-06-26 2014-06-26
PCT/US2014/062892 WO2015066176A1 (en) 2013-10-30 2014-10-29 Enteric soft capsules comprising polyunsaturated fatty acids

Publications (1)

Publication Number Publication Date
MX2016004487A true MX2016004487A (es) 2016-11-10

Family

ID=52995731

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016004487A MX2016004487A (es) 2013-10-30 2014-10-29 Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.

Country Status (6)

Country Link
US (2) US9895332B2 (es)
EP (2) EP3062785B1 (es)
CA (1) CA2926335C (es)
ES (1) ES2826201T3 (es)
MX (1) MX2016004487A (es)
WO (1) WO2015066176A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6317425B2 (ja) 2013-03-15 2018-04-25 パセオン ソフトジェルズ インコーポレイティド シルク系カプセル剤
US9895332B2 (en) * 2013-10-30 2018-02-20 Patheon Softgels, Inc. Enteric soft capsules comprising polyunsaturated fatty acids
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
CN106135376B (zh) * 2015-03-30 2019-03-22 维斯克凡科技（苏州）有限公司 用于可食性胶原肠衣的端部封闭部以及获得该端部封闭部的方法
WO2016179137A1 (en) * 2015-05-04 2016-11-10 Cytometix, Inc. Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs
WO2016205701A1 (en) 2015-06-19 2016-12-22 University Of Southern California Enteral fast access tract platform system
WO2016205754A1 (en) 2015-06-19 2016-12-22 University Of Southern California Compositions and methods for modified nutrient delivery
US20170304150A1 (en) * 2016-04-19 2017-10-26 Ascent Pharmaceuticals, Inc. Stable packaging system for moisture and oxygen sensitive pharmaceutical dosage forms
KR102296142B1 (ko) * 2016-07-06 2021-08-31 쿠오리카프스 가부시키가이샤 경도가 개선된 경질 캡슐 및 그 제조 방법
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
US20210236644A1 (en) 2017-11-10 2021-08-05 Cocoon Biotech Inc. Ocular applications of silk-based products
CN112996500A (zh) * 2018-06-15 2021-06-18 优美佳生物技术有限公司 用于调节elovl2的组合物和方法
CN109528679B (zh) * 2019-01-15 2023-03-14 南宁富莱欣生物科技有限公司 一种包含多种维生素的软胶囊及其生产方法
US20220400724A1 (en) * 2019-10-28 2022-12-22 R.P. Scherer Technologies, Llc Delayed release softgel capsules in higher ph environment
US20230225980A1 (en) * 2020-06-02 2023-07-20 R.P. Scherer Technologies, Llc Delayed release softgel capsules
IT202100008483A1 (it) * 2021-04-06 2022-10-06 Stefano Sala Kit per il rilascio controllato di sostanze volatili
AU2022305950A1 (en) * 2021-07-06 2024-02-08 R.P. Scherer Technologies, Llc Softgel capsule
CN113598376B (zh) * 2021-08-11 2023-11-21 郑州瑞普生物工程有限公司 一种应用于含铜离子片剂产品中的叶酸微囊粉的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US6482516B1 (en) 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
EP1545475B1 (en) 2002-10-01 2014-07-16 Banner Pharmacaps, Inc. Enteric composition for the manufacture of soft capsule wall
GB0403247D0 (en) * 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US7022713B2 (en) 2004-02-19 2006-04-04 Kowa Co., Ltd. Hyperlipemia therapeutic agent
AU2006322990A1 (en) * 2005-10-07 2007-06-14 Ocean Nutrition Canada Ltd. Salts of fatty acids and methods of making and using thereof
US20070148248A1 (en) 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
US20120171285A1 (en) * 2007-06-01 2012-07-05 Opheim Joar A Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
CA2692394A1 (en) 2007-07-06 2009-01-15 Seth J. Baum Fatty acid compositions and methods of use
NZ627238A (en) * 2009-04-29 2016-02-26 Amarin Pharmaceuticals Ie Ltd Stable pharmaceutical composition comprising ethyl eicosapentaenoate
US20110177061A1 (en) 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
CA2706270C (en) 2010-06-03 2020-01-07 Accucaps Industries Limited Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
KR20130139896A (ko) * 2010-09-08 2013-12-23 프로노바 바이오파마 너지 에이에스 유리산 형태의 epa 및 dha, 계면활성제, 및 스타틴을 포함하는 조성물
WO2012032414A2 (en) 2010-09-08 2012-03-15 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture, a surfactant, and a statin
KR20130103521A (ko) 2010-09-08 2013-09-23 프로노바 바이오파마 너지 에이에스 지방산 오일 혼합물, 유리 지방산, 및 스타틴을 포함하는 조성물
EP2800563B1 (en) 2012-01-06 2018-07-11 Omthera Pharmaceuticals Inc. Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
EP2833881A1 (en) 2012-04-04 2015-02-11 Pronova BioPharma Norge AS Compositions comprising omega-3 fatty acids and vitamin d for psoriasis, and methods and uses thereof
JP2015512945A (ja) 2012-04-13 2015-04-30 バナー ファーマキャップス，インコーポレイティド 錠剤と液体または半固体の充填剤とを含む軟質弾性カプセル、ならびにそれらの製造方法
US9895332B2 (en) * 2013-10-30 2018-02-20 Patheon Softgels, Inc. Enteric soft capsules comprising polyunsaturated fatty acids
US9895333B2 (en) * 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids

Also Published As

Publication number Publication date
EP3062785B1 (en) 2020-07-22
EP3062785A1 (en) 2016-09-07
ES2826201T3 (es) 2021-05-17
EP3738586A1 (en) 2020-11-18
EP3062785A4 (en) 2017-07-19
US20180169051A1 (en) 2018-06-21
CA2926335A1 (en) 2015-05-07
US10188624B2 (en) 2019-01-29
US9895332B2 (en) 2018-02-20
CA2926335C (en) 2021-11-23
US20150118298A1 (en) 2015-04-30
WO2015066176A1 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
NZ702325A (en) Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
HK1205096A1 (en) Method for the preparation of triglycerides of medium-chain length fatty acids
HK1205645A1 (en) Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids rrr-
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2014000770A (es) Composiciones de acidos grasos.
EA201791885A1 (ru) Смесь жирных кислот и её применение для лечения воспалительных патологий
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
MA40417A (fr) Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques
NZ734149A (en) Millicapsule formulations comprising polyunsaturated free fatty acids
HK1252244A1 (zh) 含游離多元不飽和脂肪酸組合物及其製造方法
WO2014165190A3 (en) Compositions comprising docosapentaenoic acid and methods of use
EP3109315A4 (en) Method for the enrichment of microalgae biomass in polyunsaturated fatty acids
HK1223126A1 (zh) 不飽和脂肪酸酶和二十碳五烯酸的製備方法
EP3673073A4 (en) PRODUCTION OF EPA- AND DHA-ENRICHED GLYCERIDES
TW201613571A (en) OMWGA-3 compositions, dosage forms, and methods of use
EP3076961A4 (en) Omega-3 fatty acid articles of manufacture, and methods and apparatus for making same
EP3027180A4 (en) Compositions and methods of the treatment of fatty acid metabolism disorders
PH12018502207A1 (en) Methods of manufacturing nutritional formulations
EP3585375A4 (en) FORMULATIONS CONTAINING OMEGA-3 FATTY ACIDS OR ESTERS OF THEM AND MAQUI BERRY EXTRACT AND THEIR THERAPEUTIC USES
EA201890479A1 (ru) Гидрофобный гель на основе витамина е без продуктов силикона для местного применения
GB201209344D0 (en) Omega-6 enriched pufa phospholipids
WO2014140934A3 (en) Natural lipids containing non-oxidizable fatty acids
EP3303280A4 (en) METHOD AND COMPOSITIONS FOR PREPARING TRIGLYCERIDES WITH THE FUNCTIONALITY OF VICINAL DIESTER WITH FATTY ACID